Home · Company · About

Built by people who have run this function

INFERIVA exists because the systems sold into these markets were designed for somewhere else, and assessed by instruments that accept description in place of evidence.

What we build

A financial crime operations platform — onboarding, screening, monitoring, cases and filing — with money laundering and fraud handled as one estate and a specialist layer where agent networks and wallets carry the volume.

And a separate assurance instrument, because a platform assessing its own controls is a self-assessment however good its data.

What we are honest about

We are early. We have a production tenant, a platform that files to a regulator, and an assessment instrument we have run against our own systems and found things with.

We do not yet have SOC 2 Type II, we have not demonstrated screening at the volume a systemic institution requires, and our obligation mappings have not been through qualified counsel in every market. We keep that list and we will show it to you — it is shorter than the one on the other side, and a vendor who cannot tell you what they have not done is a vendor who has not checked.

An examination you fail in private costs nothing. That applies to us as much as to anybody we assess.

Where we work

Lagos and London, serving institutions across West Africa, East Africa, Southern Africa and the United Kingdom. The platform is configured per jurisdiction rather than rebuilt per market, so where we go next is a question of demand rather than engineering.

Next

See it with your rules, not our demo data

Tell us where you operate and what you sell, and we will show you the platform configured the way it would actually run for you.

What happens next

One of us reads it, not a queue. We come back inside two working days with a time — or a straight answer about whether we are the right fit.

So we can configure the demonstration before we speak.

We use this to reply to you and nothing else. No newsletter, no list.

FINANCIAL CRIME. UNIFIED.